Within the TME, CD8+ T cells interact with diverse immune cell populations, including tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), and regulatory T cells (Tregs), profoundly influencing immune responses and tumor outcomes. Here, CD8A is linked to neoplasm.